Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 197 articles:
HTML format

Single Articles

    May 2021
  1. CHEN Z, Zhong T, Zhong J, Tang Y, et al
    MicroRNA129 inhibits colorectal cancer cell proliferation, invasion and epithelialtomesenchymal transition by targeting SOX4.
    Oncol Rep. 2021;45.
    PubMed     Abstract available

    April 2021
  2. PARK SY, Kim JT, Park ES, Hwang YS, et al
    Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calciummediated cell signaling.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

  3. ZHANG P, Yuan X, Yu T, Huang H, et al
    Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

  4. SUETSUGU T, Mori R, Futamura M, Fukada M, et al
    Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Oncol Rep. 2021;45:1-8.
    PubMed     Abstract available

  5. POTURNAJOVA M, Furielova T, Balintova S, Schmidtova S, et al
    Molecular features and gene expression signature of metastatic colorectal cancer (Review).
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

    March 2021
  6. VERDINA A, Di Segni M, Amoreo CA, Sperduti I, et al
    HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Oncol Rep. 2021;45:899-910.
    PubMed     Abstract available

  7. WANG X, Song Z, Hu B, Chen Z, et al
    MicroRNA642a5p inhibits colon cancer cell migration and invasion by targeting collagen type I alpha1.
    Oncol Rep. 2021;45:933-944.
    PubMed     Abstract available

    December 2020
  8. GUO Z, Zhang X, Zhu H, Zhong N, et al
    TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2.
    Oncol Rep. 2020 Dec 9. doi: 10.3892/or.2020.7890.
    PubMed     Abstract available

  9. CHEN D, Wang R, Long M, Li W, et al
    Identification of in vitro and in vivo oncolytic effect in colorectal cancer cells by Orf virus strain NA1/11.
    Oncol Rep. 2020 Dec 8. doi: 10.3892/or.2020.7885.
    PubMed     Abstract available

  10. HA HA, Chiang JH, Tsai FJ, Bau DT, et al
    Novel quinazolinone MJ33 induces AKT/mTORmediated autophagyassociated apoptosis in 5FUresistant colorectal cancer cells.
    Oncol Rep. 2020 Dec 3. doi: 10.3892/or.2020.7882.
    PubMed     Abstract available

    November 2020
  11. ZHANG JX, Qin MB, Ye Z, Peng P, et al
    Association of tricellulin expression with poor colorectal cancer prognosis and metastasis.
    Oncol Rep. 2020;44:2174-2184.
    PubMed     Abstract available

    October 2020
  12. ESPINOZA I, Agarwal S, Reddy A, Shenoy V, et al
    Expression of trefoil factor 3 is decreased in colorectal cancer.
    Oncol Rep. 2020 Oct 30. doi: 10.3892/or.2020.7829.
    PubMed     Abstract available

  13. ZHANG HG, Wang FJ, Wang Y, Zhao ZX, et al
    lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR34a/mTOR/SIRT1 pathway in colorectal cancer.
    Oncol Rep. 2020 Oct 26. doi: 10.3892/or.2020.7825.
    PubMed     Abstract available

  14. ZHANG XW, Li SL, Zhang D, Sun XL, et al
    RP11619L19.2 promotes colon cancer development by regulating the miR12715p/CD164 axis.
    Oncol Rep. 2020 Oct 7. doi: 10.3892/or.2020.7794.
    PubMed     Abstract available

  15. WANG G, Yu Y, Wang YZ, Zhu ZM, et al
    Effects and mechanisms of fatty acid metabolismmediated glycolysis regulated by betulinic acidloaded nanoliposomes in colorectal cancer.
    Oncol Rep. 2020 Oct 1. doi: 10.3892/or.2020.7787.
    PubMed     Abstract available

  16. CHIANG JH, Tsai FJ, Hsu YM, Yin MC, et al
    Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells.
    Oncol Rep. 2020;44:1415-1424.
    PubMed     Abstract available

    September 2020
  17. HE J, Zhao H, Liu X, Wang D, et al
    Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosomemediated circHMGCS1 via the miR34a5p/SGPP1 axis.
    Oncol Rep. 2020 Sep 29. doi: 10.3892/or.2020.7783.
    PubMed     Abstract available

  18. WANG X, Tao G, Huang D, Liang S, et al
    Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA4855p/CKS1B axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7758.
    PubMed     Abstract available

  19. YANG H, Li Q, Wu Y, Dong J, et al
    Long noncoding RNA RP11400N13.3 promotes the progression of colorectal cancer by regulating the miR47223p/P2RY8 axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7755.
    PubMed     Abstract available

  20. WEN L, Zhang X, Zhang J, Chen S, et al
    Paxillin knockdown suppresses metastasis and epithelialmesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Oncol Rep. 2020;44:1105-1115.
    PubMed     Abstract available

  21. XU J, Chen Q, Tian K, Liang R, et al
    m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Oncol Rep. 2020;44:973-986.
    PubMed     Abstract available

  22. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    Long noncoding RNA UCID sponges miR1523p to promote colorectal cancer cell migration and invasion via the Wnt/betacatenin signaling pathway.
    Oncol Rep. 2020;44:1194-1205.
    PubMed     Abstract available

    August 2020
  23. LIANG Y, Lv Z, Huang G, Qin J, et al
    Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7729.
    PubMed     Abstract available

  24. HONG S, Cai W, Huang Z, Wang Y, et al
    Ginsenoside Rg3 enhances the anticancer effect of 5FU in colon cancer cells via the PI3K/AKT pathway.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7728.
    PubMed     Abstract available

  25. PEREZ AG, Andrade-Da-Costa J, De Souza WF, De Souza Ferreira M, et al
    Nglycosylation and receptor tyrosine kinase signaling affect claudin3 levels in colorectal cancer cells.
    Oncol Rep. 2020 Aug 11. doi: 10.3892/or.2020.7727.
    PubMed     Abstract available

  26. JING L, Feng L, Zhou Z, Shi S, et al
    TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
    Oncol Rep. 2020;44:628-636.
    PubMed     Abstract available

  27. SHI DD, Yang CG, Han S, Wang SY, et al
    Dynamic evaluation of mesenchymal circulating tumor cells in patients with colorectal cancer: Clinical associations and prognostic value.
    Oncol Rep. 2020;44:757-767.
    PubMed     Abstract available

  28. HUANG C, He C, Ruan P, Zhou R, et al
    TSPYL5 activates endoplasmic reticulum stress to inhibit cell proliferation, migration and invasion in colorectal cancer.
    Oncol Rep. 2020;44:449-456.
    PubMed     Abstract available

    July 2020
  29. SUN Y, Liu Y, Cai Y, Han P, et al
    Downregulation of LINC00958 inhibits proliferation, invasion and migration, and promotes apoptosis of colorectal cancer cells by targeting miR36195p.
    Oncol Rep. 2020 Jul 29. doi: 10.3892/or.2020.7707.
    PubMed     Abstract available

  30. WANG W, Wang H, Xiang L, Ni T, et al
    DJ1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Oncol Rep. 2020;44:77-90.
    PubMed     Abstract available

    May 2020
  31. ZHAO J, Li G, Wei J, Dang S, et al
    Ellagic acid induces cell cycle arrest and apoptosis via the TGFbeta1/Smad3 signaling pathway in human colon cancer HCT116 cells.
    Oncol Rep. 2020 May 20. doi: 10.3892/or.2020.7617.
    PubMed     Abstract available

    April 2020
  32. LI P, He C, Gao A, Yan X, et al
    RAD18 promotes colorectal cancer metastasis by activating the epithelialmesenchymal transition pathway.
    Oncol Rep. 2020 Apr 21. doi: 10.3892/or.2020.7590.
    PubMed     Abstract available

  33. WANG H, Liu S, Kong F, Xiao F, et al
    Spred2 inhibits epithelialmesenchymal transition of colorectal cancer cells by impairing ERK signaling.
    Oncol Rep. 2020 Apr 16. doi: 10.3892/or.2020.7586.
    PubMed     Abstract available

  34. YASSIN S, Hu J, Xu H, Li C, et al
    [Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT116 xenograft model in nude mice.
    Oncol Rep. 2020;43:1349.
    PubMed     Abstract available

    March 2020
  35. MATSUMOTO A, Shimada Y, Nakano M, Oyanagi H, et al
    RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Oncol Rep. 2020 Mar 23. doi: 10.3892/or.2020.7561.
    PubMed     Abstract available

    February 2020
  36. YAN X, Li M, Chen L, Peng X, et al
    alphaSolanine inhibits growth and metastatic potential of human colorectal cancer cells.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7519.
    PubMed     Abstract available

  37. ZHANG NN, Lin T, Xiao M, Li QS, et al
    Transcriptome sequencing analysis of monoADPribosylation in colorectal cancer cells.
    Oncol Rep. 2020 Feb 24. doi: 10.3892/or.2020.7516.
    PubMed     Abstract available

  38. TONG G, Zhang G, Liu J, Zheng Z, et al
    Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC8 stratification.
    Oncol Rep. 2020 Feb 21. doi: 10.3892/or.2020.7511.
    PubMed     Abstract available

  39. ZHAN J, Tong J, Fu Q
    Long noncoding RNA LINC00858 promotes TP53wildtype colorectal cancer progression by regulating the microRNA253p/SMAD7 axis.
    Oncol Rep. 2020 Feb 18. doi: 10.3892/or.2020.7506.
    PubMed     Abstract available

  40. JIANG X, Li D, Wang G, Liu J, et al
    Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
    Oncol Rep. 2020 Feb 13. doi: 10.3892/or.2020.7502.
    PubMed     Abstract available

  41. ZHOU L, Sui H, Wang T, Jia R, et al
    Tanshinone IIA reduces secretion of proangiogenic factors and inhibits angiogenesis in human colorectal cancer.
    Oncol Rep. 2020 Feb 12. doi: 10.3892/or.2020.7498.
    PubMed     Abstract available

  42. HAO Q, Wang M, Sun NX, Zhu C, et al
    Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2UDP glucuronosyltransferase 1A metabolic axis activation.
    Oncol Rep. 2020 Feb 10. doi: 10.3892/or.2020.7495.
    PubMed     Abstract available

  43. QIAO PF, Yao L, Zeng ZL
    Catalpolmediated microRNA34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer.
    Oncol Rep. 2020 Feb 7. doi: 10.3892/or.2020.7494.
    PubMed     Abstract available

  44. WANG K, Zheng J, Yu J, Wu Y, et al
    Knockdown of MMP1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/cmyc signaling pathway and EMT.
    Oncol Rep. 2020 Feb 6. doi: 10.3892/or.2020.7490.
    PubMed     Abstract available

  45. ZHANG Y, Huang WJ, Yang QR, Zhang HD, et al
    Cryopreserved biopsy tissues of rectal cancer liver metastasis for assessment of anticancer drug response in vitro and in vivo.
    Oncol Rep. 2020;43:405-414.
    PubMed     Abstract available

    January 2020
  46. CHEN Y, Yang Z, Deng B, Wu D, et al
    Interleukin 1beta/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy.
    Oncol Rep. 2020 Jan 22. doi: 10.3892/or.2020.7475.
    PubMed     Abstract available

  47. FENG Y, Ji D, Huang Y, Ji B, et al
    TGM3 functions as a tumor suppressor by repressing epithelialtomesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Oncol Rep. 2020 Jan 21. doi: 10.3892/or.2020.7474.
    PubMed     Abstract available

    December 2019
  48. HOU B, Li W, Li J, Ma J, et al
    Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Oncol Rep. 2019 Dec 20. doi: 10.3892/or.2019.7442.
    PubMed     Abstract available

  49. LI FS, Huang J, Cui MZ, Zeng JR, et al
    BMP9 mediates the anticancer activity of evodiamine through HIF1alpha/p53 in human colon cancer cells.
    Oncol Rep. 2019 Dec 11. doi: 10.3892/or.2019.7427.
    PubMed     Abstract available

  50. KATO J, Shirakami Y, Ohnishi M, Mizutani T, et al
    Suppressive effects of the sodiumglucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice.
    Oncol Rep. 2019;42:2797-2805.
    PubMed     Abstract available

  51. LIU H, Liu J, Huo J, Li K, et al
    Downregulation of miR143 modulates KRAS expression in colorectal carcinoma cells.
    Oncol Rep. 2019;42:2759-2767.
    PubMed     Abstract available

    November 2019
  52. QIAN Z, Gong L, Mou Y, Han Y, et al
    MicroRNA203a3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.
    Oncol Rep. 2019;42:1825-1832.
    PubMed     Abstract available

  53. LI JM, Jiang GM, Zhao L, Yang F, et al
    Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatinresistant cell line to oxaliplatin by inhibiting excision repair crosscomplementing group 1 protein expression.
    Oncol Rep. 2019;42:1725-1734.
    PubMed     Abstract available

    October 2019
  54. ISHIKAWA K, Kawano Y, Arihara Y, Kubo T, et al
    BH3 profiling discriminates the antiapoptotic status of 5fluorouracilresistant colon cancer cells.
    Oncol Rep. 2019 Oct 15. doi: 10.3892/or.2019.7373.
    PubMed     Abstract available

  55. LV Y, Xie B, Bai B, Shan L, et al
    Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Oncol Rep. 2019 Oct 14. doi: 10.3892/or.2019.7368.
    PubMed     Abstract available

  56. WU B, Sun D, Ma L, Deng Y, et al
    Exosomes isolated from CAPS1overexpressing colorectal cancer cells promote cell migration.
    Oncol Rep. 2019 Oct 9. doi: 10.3892/or.2019.7361.
    PubMed     Abstract available

  57. NEGRI F, Bozzetti C, Pedrazzi G, Azzoni C, et al
    High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7349.
    PubMed     Abstract available

    September 2019
  58. DHO SH, Cho EH, Lee JY, Lee SY, et al
    A novel therapeutic antiCD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells.
    Oncol Rep. 2019 Sep 26. doi: 10.3892/or.2019.7337.
    PubMed     Abstract available

  59. RUAN GT, Gong YZ, Liao XW, Wang S, et al
    Diagnostic and prognostic values of CXC motif chemokine ligand 3 in patients with colon cancer.
    Oncol Rep. 2019 Sep 19. doi: 10.3892/or.2019.7326.
    PubMed     Abstract available

  60. SHU W, Liu G, Dai Y, Feng A, et al
    The oncogenic role of NKAP in the growth and invasion of colon cancer cells.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7322.
    PubMed     Abstract available

  61. JIANG X, Shen TY, Lu H, Shi C, et al
    Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7324.
    PubMed     Abstract available

  62. LI Y, Xi Y, Zhu G, Jia J, et al
    Downregulated IGFBP7 facilitates liver metastasis by modulating epithelialmesenchymal transition in colon cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7303.
    PubMed     Abstract available

  63. SAWADA R, Arai Y, Sagawa Y, Nagata Y, et al
    High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7304.
    PubMed     Abstract available

  64. TANAKAYA K, Kumamoto K, Tada Y, Eguchi H, et al
    A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and earlyonset cancer: A case report.
    Oncol Rep. 2019;42:1133-1140.
    PubMed     Abstract available

  65. GONG YZ, Ruan GT, Liao XW, Wang XK, et al
    Diagnostic and prognostic values of integrin alpha subfamily mRNA expression in colon adenocarcinoma.
    Oncol Rep. 2019;42:923-936.
    PubMed     Abstract available

    August 2019
  66. HONG HK, Pyo DH, Kim TW, Yun NH, et al
    Efficient primary culture model of patientderived tumor cells from colorectal cancer using a Rhoassociated protein kinase inhibitor and feeder cells.
    Oncol Rep. 2019 Aug 20. doi: 10.3892/or.2019.7285.
    PubMed     Abstract available

  67. LI J, He J, Wang Y, Shu Y, et al
    SMC1 promotes proliferation and inhibits apoptosis through the NFkappaB signaling pathway in colorectal cancer.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7273.
    PubMed     Abstract available

  68. GU J, Wang L, Li T, Tang S, et al
    Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.
    Oncol Rep. 2019 Aug 7. doi: 10.3892/or.2019.7267.
    PubMed     Abstract available

  69. TONG J, Shen Y, Chen X, Wang R, et al
    FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.
    Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7259.
    PubMed     Abstract available

  70. CHEN L, Chen L, Wan L, Huo Y, et al
    Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3alpha signaling pathway in C2C12 myotubes and mice.
    Oncol Rep. 2019;42:479-494.
    PubMed     Abstract available

    July 2019
  71. TANAKA E, Miyakawa Y, Kishikawa T, Seimiya T, et al
    Expression of circular RNA CDR1AS in colon cancer cells increases cell surface PDL1 protein levels.
    Oncol Rep. 2019 Jul 19. doi: 10.3892/or.2019.7244.
    PubMed     Abstract available

  72. LI H, Lai Z, Yang H, Peng J, et al
    Hedyotis diffusa Willd. inhibits VEGFCmediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
    Oncol Rep. 2019 Jul 5. doi: 10.3892/or.2019.7223.
    PubMed     Abstract available

  73. CHEN Y, Yang Z, Wu D, Min Z, et al
    Upregulation of interleukin17F in colorectal cancer promotes tumor invasion by inducing epithelialmesenchymal transition.
    Oncol Rep. 2019 Jul 4. doi: 10.3892/or.2019.7220.
    PubMed     Abstract available

  74. WANG Y, Zhou L, Qing Q, Li Y, et al
    Gene expression profile of cancer stemlike cells in the SW480 colon adenocarcinoma cell line.
    Oncol Rep. 2019;42:386-398.
    PubMed     Abstract available

  75. ANDO N, Hara M, Shiga K, Yanagita T, et al
    Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL6 and VEGF from colon cancerassociated fibroblasts.
    Oncol Rep. 2019;42:339-349.
    PubMed     Abstract available

    May 2019
  76. XIONG W, Wang X, Cai X, Xiong W, et al
    Identification of tRNAderived fragments in colon cancer by comprehensive small RNA sequencing.
    Oncol Rep. 2019 May 31. doi: 10.3892/or.2019.7178.
    PubMed     Abstract available

  77. WAN Z, Chai R, Yuan H, Chen B, et al
    MEIS2 promotes cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 May 15. doi: 10.3892/or.2019.7161.
    PubMed     Abstract available

  78. YIN J, Qi W, Ji CG, Zhang DX, et al
    Small RNA sequencing revealed aberrant piRNA expression profiles in colorectal cancer.
    Oncol Rep. 2019 May 13. doi: 10.3892/or.2019.7158.
    PubMed     Abstract available

  79. KITAGAWA H, Kitajima Y, Kai K, Komukai S, et al
    Predictive value of the ratio of 8hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer.
    Oncol Rep. 2019;41:3041-3050.
    PubMed     Abstract available

  80. QIAN W, Feng Y, Li J, Peng W, et al
    Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
    Oncol Rep. 2019;41:3027-3040.
    PubMed     Abstract available

  81. BANH T, Snoke D, Cole RM, Angelotti A, et al
    Higher tumor mass and lower adipose mass are associated with colon26 adenocarcinomainduced cachexia in male, female and ovariectomized mice.
    Oncol Rep. 2019;41:2909-2918.
    PubMed     Abstract available

  82. WANG JQ, Tang Y, Li QS, Xiao M, et al
    PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NFkappaB in tumour metastases of colon carcinoma.
    Oncol Rep. 2019;41:2657-2666.
    PubMed     Abstract available

    April 2019
  83. YAO Y, Rao C, Zheng G, Wang S, et al
    Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR384/pleiotrophin axis.
    Oncol Rep. 2019 Apr 24. doi: 10.3892/or.2019.7136.
    PubMed     Abstract available

  84. SHIRATORI H, Kawai K, Hata K, Tanaka T, et al
    The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.
    Oncol Rep. 2019 Apr 23. doi: 10.3892/or.2019.7134.
    PubMed     Abstract available

  85. JIANG J, Li Y, Jiang Z
    Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2019 Apr 17. doi: 10.3892/or.2019.7126.
    PubMed     Abstract available

  86. XU C, Yu X, Zhu Y, Cai Z, et al
    Overexpression of calpain1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA.
    Oncol Rep. 2019 Apr 16. doi: 10.3892/or.2019.7121.
    PubMed     Abstract available

  87. ZHANG H, Song Y, Yang C, Wu X, et al
    Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 Apr 9. doi: 10.3892/or.2019.7106.
    PubMed     Abstract available

    March 2019
  88. CHENG Z, Shao X, Xu M, Wang J, et al
    Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Oncol Rep. 2019 Mar 15. doi: 10.3892/or.2019.7071.
    PubMed     Abstract available

  89. ZHANG T, Liu L, Lai W, Zeng Y, et al
    Interaction with tumorassociated macrophages promotes PRL3induced invasion of colorectal cancer cells via MAPK pathwayinduced EMT and NFkappaB signalinginduced angiogenesis.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7049.
    PubMed     Abstract available

    February 2019
  90. NAGASU S, Sudo T, Kinugasa T, Yomoda T, et al
    Yboxbinding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7038.
    PubMed     Abstract available

  91. XU J, Qian J, Zhang W, Chen E, et al
    LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL6 and TNFalpha.
    Oncol Rep. 2019 Feb 26. doi: 10.3892/or.2019.7034.
    PubMed     Abstract available

  92. JIANG Y, Cai Y, Shao W, Li F, et al
    MicroRNA144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7025.
    PubMed     Abstract available

  93. ALCANTARA KMM, Garcia RL
    MicroRNA92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Oncol Rep. 2019 Feb 19. doi: 10.3892/or.2019.7020.
    PubMed     Abstract available

    January 2019
  94. LV Z, He K, Shi L, Shi K, et al
    Interaction between C2ORF68 and HuR in human colorectal cancer.
    Oncol Rep. 2019 Jan 21. doi: 10.3892/or.2019.6973.
    PubMed     Abstract available

  95. TIAN W, Du Y, Ma Y, Zhang B, et al
    miR663aTTC22V1 axis inhibits colon cancer metastasis.
    Oncol Rep. 2019 Jan 16. doi: 10.3892/or.2019.6969.
    PubMed     Abstract available

    December 2018
  96. GUO L, Ma L, Liu C, Lei Y, et al
    ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6943.
    PubMed     Abstract available

  97. RYU TY, Kim K, Son MY, Min JK, et al
    Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6938.
    PubMed     Abstract available

  98. LI N, Li D, Du Y, Su C, et al
    Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6914.
    PubMed     Abstract available

    November 2018
  99. MARQUEZ J, Kratchmarova I, Akimov V, Unda F, et al
    NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells.
    Oncol Rep. 2018 Nov 27. doi: 10.3892/or.2018.6892.
    PubMed     Abstract available

  100. KITAMURA H, Takemura H, Minamoto T
    Tumor p16INK4 gene expression and prognosis in colorectal cancer.
    Oncol Rep. 2018 Nov 26. doi: 10.3892/or.2018.6884.
    PubMed     Abstract available

  101. CHEN Y, Liu Y, Zhou Y, You H, et al
    Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
    Oncol Rep. 2018 Nov 21. doi: 10.3892/or.2018.6877.
    PubMed     Abstract available

  102. MA Y, Chen Y, Lin C, Hu G, et al
    Biological functions and clinical significance of the newly identified long noncoding RNA RP185F18.6 in colorectal cancer.
    Oncol Rep. 2018;40:2648-2658.
    PubMed     Abstract available

  103. AKAGI J, Baba H
    Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6841.
    PubMed     Abstract available

  104. ZHANG T, Guo J, Gu J, Wang Z, et al
    Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6840.
    PubMed     Abstract available

    October 2018
  105. AI X, Lei Q, Shen X, Li J, et al
    Long noncoding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6834.
    PubMed     Abstract available

  106. TANG B, Liang W, Liao Y, Li Z, et al
    PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 25. doi: 10.3892/or.2018.6825.
    PubMed     Abstract available

  107. MUN JG, Kee JY, Han YH, Lee S, et al
    Galla Rhois water extract inhibits lung metastasis by inducing AMPKmediated apoptosis and suppressing metastatic properties of colorectal cancer cells.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6812.
    PubMed     Abstract available

  108. ZHANG Z, Zhong X, Xiao Y, Chen C, et al
    MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
    Oncol Rep. 2018 Oct 18. doi: 10.3892/or.2018.6806.
    PubMed     Abstract available

  109. DING L, Gu H, Lan Z, Lei Q, et al
    Downregulation of cyclooxygenase1 stimulates mitochondrial apoptosis through the NFkappaB signaling pathway in colorectal cancer cells.
    Oncol Rep. 2018 Oct 12. doi: 10.3892/or.2018.6785.
    PubMed     Abstract available

  110. WU J, Zhao R, Lin J, Liu B, et al
    Integrin beta4 reduces DNA damageinduced p53 activation in colorectal cancer.
    Oncol Rep. 2018;40:2183-2192.
    PubMed     Abstract available

  111. LIU BS, Xia HW, Zhou S, Liu Q, et al
    Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.
    Oncol Rep. 2018;40:2171-2182.
    PubMed     Abstract available

  112. QIAO P, Li S, Zhang H, Yao L, et al
    Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR135A1/CCNG2 signaling pathway.
    Oncol Rep. 2018;40:2067-2078.
    PubMed     Abstract available

  113. ALSAMMAN K, El-Masry OS
    Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
    Oncol Rep. 2018;40:2157-2162.
    PubMed     Abstract available

  114. WEI HT, Guo EN, Liao XW, Chen LS, et al
    Genomescale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Oncol Rep. 2018;40:1947-1958.
    PubMed     Abstract available

    September 2018
  115. CHEN Y, Huang Y, Lu X, Wang G, et al
    Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation.
    Oncol Rep. 2018 Sep 26. doi: 10.3892/or.2018.6738.
    PubMed     Abstract available

  116. XIE B, Zhao R, Bai B, Wu Y, et al
    Identification of key tumorigenesisrelated genes and their microRNAs in colon cancer.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6726.
    PubMed     Abstract available

  117. JANG SW, Park WJ, Min H, Kwon TK, et al
    Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
    Oncol Rep. 2018 Sep 18. doi: 10.3892/or.2018.6712.
    PubMed     Abstract available

  118. LIN WC, Wang WH, Lin YH, Leu JD, et al
    Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinomabearing mouse model.
    Oncol Rep. 2018;40:1390-1400.
    PubMed     Abstract available

    August 2018
  119. ZHOU N, Sun Z, Li N, Ge Y, et al
    miR197 promotes the invasion and migration of colorectal cancer by targeting insulinlike growth factorbinding protein 3.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6640.
    PubMed     Abstract available

  120. LU J, Zhang L, Zhou H, Du Z, et al
    Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Oncol Rep. 2018;40:887-894.
    PubMed     Abstract available

  121. PENG W, Tan S, Xu Y, Wang L, et al
    LCMS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
    Oncol Rep. 2018;40:1026-1034.
    PubMed     Abstract available

    July 2018
  122. NIE S, Huang Y, Shi M, Qian X, et al
    Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6594.
    PubMed     Abstract available

  123. JI B, Feng Y, Sun Y, Ji D, et al
    GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelialmesenchymal transition through PI3K/AKT signaling activation.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6582.
    PubMed     Abstract available

  124. CHENG K, Zhao Z, Wang G, Wang J, et al
    lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR1825p/FOXO3a axis.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6584.
    PubMed     Abstract available

  125. LI JW, Huang CZ, Li JH, Yuan JH, et al
    Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6581.
    PubMed     Abstract available

  126. YANG X, Liu W, Xu X, Zhu J, et al
    Downregulation of long noncoding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelialmesenchymal transition in colorectal cancer cells.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6573.
    PubMed     Abstract available

  127. JIANG T, Li H, Jiang R, Li H, et al
    Pin2/TRF1binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factorkappaB signaling pathway.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6570.
    PubMed     Abstract available

  128. IIDA M, Hazama S, Tsunedomi R, Tanaka H, et al
    Overexpression of miR221 and miR222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6575.
    PubMed     Abstract available

  129. SONG J, Wang L, Ma Q, Yang Y, et al
    Let7i5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikreinrelated peptidase 6.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6577.
    PubMed     Abstract available

  130. LI Y, Xin S, Wu H, Xing C, et al
    High expression of microRNA31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6571.
    PubMed     Abstract available

  131. FENG Y, Dong YW, Song YN, Xiao JH, et al
    MicroRNA449a is a potential predictor of colitisassociated colorectal cancer progression.
    Oncol Rep. 2018 Jul 12. doi: 10.3892/or.2018.6566.
    PubMed     Abstract available

  132. ZHANG H, Deng Z, Zhang D, Li H, et al
    High expression of leucinerich repeatcontaining 8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6556.
    PubMed     Abstract available

  133. XU Y, Liu X, Zhang H, Zhu Z, et al
    Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2018 Jul 2. doi: 10.3892/or.2018.6539.
    PubMed     Abstract available

  134. BI C, Jiang B
    Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.
    Oncol Rep. 2018;40:283-293.
    PubMed     Abstract available

    June 2018
  135. LIU M, Zhang X, Cai J, Li Y, et al
    Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6525.
    PubMed     Abstract available

  136. GUO Y, Wang M, Jia X, Zhu H, et al
    Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6494.
    PubMed     Abstract available

  137. ZHANG Y, Wang S, Qian W, Ji D, et al
    uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Oncol Rep. 2018 Jun 7. doi: 10.3892/or.2018.6480.
    PubMed     Abstract available

  138. NIKOLOUZAKIS TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, et al
    Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
    Oncol Rep. 2018;39:2455-2472.
    PubMed     Abstract available

    May 2018
  139. TAMURA S, Isobe T, Ariyama H, Nakano M, et al
    Ecadherin regulates proliferation of colorectal cancer stem cells through NANOG.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6464.
    PubMed     Abstract available

  140. ZHU D, Sun Y, Zhang D, Dong M, et al
    miR1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6463.
    PubMed     Abstract available

  141. MENG Q, Chen Y, Lian B, Shang Y, et al
    miR218 promotes apoptosis of SW1417 human colon cancer cells by targeting cFLIP.
    Oncol Rep. 2018 May 23. doi: 10.3892/or.2018.6460.
    PubMed     Abstract available

  142. ALQURASHI N, Hashimi SM, Alowaidi F, Ivanovski S, et al
    Dual mTOR/PI3K inhibitor NVPBEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4EBP1.
    Oncol Rep. 2018 May 22. doi: 10.3892/or.2018.6457.
    PubMed     Abstract available

  143. CUI X, Wang G, Shen W, Huang Z, et al
    Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6452.
    PubMed     Abstract available

  144. ZHENG LZ, Chen SZ
    shRNAinduced knockdown of the SPERT gene inhibits proliferation and promotes apoptosis of human colorectal cancer RKO cells.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6455.
    PubMed     Abstract available

  145. LI J, Xu J, Yan X, Jin K, et al
    MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2018 May 17. doi: 10.3892/or.2018.6449.
    PubMed     Abstract available

  146. YANG H, Wang S, Kang YJ, Wang C, et al
    Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6412.
    PubMed     Abstract available

  147. MAO L, Chen Q, Gong K, Xu X, et al
    Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells.
    Oncol Rep. 2018;39:2436-2442.
    PubMed     Abstract available

  148. YU Y, Peng K, Li H, Zhuang R, et al
    SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
    Oncol Rep. 2018;39:2235-2242.
    PubMed     Abstract available

  149. XING Y, Zhao Z, Zhu Y, Zhao L, et al
    Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Oncol Rep. 2018;39:2365-2375.
    PubMed     Abstract available

  150. LI K, Guo J, Wu Y, Jin D, et al
    Suppression of YAP by DDP disrupts colon tumor progression.
    Oncol Rep. 2018;39:2114-2126.
    PubMed     Abstract available

  151. ZHANG Z, Wang S, Ji D, Qian W, et al
    Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma.
    Oncol Rep. 2018;39:2101-2113.
    PubMed     Abstract available

    April 2018
  152. LI C, Du X, Xia S, Chen L, et al
    MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6406.
    PubMed     Abstract available

  153. FUJINO S, Kinugasa T, Sudo T, Mizobe T, et al
    Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6407.
    PubMed     Abstract available

  154. TERASAKI M, Mima M, Kudoh S, Endo T, et al
    Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
    Oncol Rep. 2018 Apr 24. doi: 10.3892/or.2018.6398.
    PubMed     Abstract available

  155. ALOWAIDI F, Hashimi SM, Alqurashi N, Alhulais R, et al
    Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6392.
    PubMed     Abstract available

  156. CHEN S, Zhang L, Su Y, Zhang X, et al
    Screening potential biomarkers for colorectal cancer based on circular RNA chips.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6372.
    PubMed     Abstract available

  157. JEONG D, Kim H, Kim D, Ban S, et al
    Protein kinase, membraneassociated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
    Oncol Rep. 2018 Apr 13. doi: 10.3892/or.2018.6371.
    PubMed     Abstract available

  158. BENEDICTO A, Romayor I, Arteta B
    CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Oncol Rep. 2018;39:2022-2030.
    PubMed     Abstract available

  159. PARK JH, Lee JM, Lee EJ, Kim DJ, et al
    Kynurenine promotes the goblet cell differentiation of HT-29 colon carcinoma cells by modulating Wnt, Notch and AhR signals.
    Oncol Rep. 2018;39:1930-1938.
    PubMed     Abstract available

    March 2018
  160. REN W, Wang T, He X, Zhang Q, et al
    betaarrestin2 promotes 5FUinduced apoptosis via the NFkappaB pathway in colorectal cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6340.
    PubMed     Abstract available

  161. LIU W, Li L, Ye H, Tao H, et al
    Role of COL6A3 in colorectal cancer.
    Oncol Rep. 2018 Mar 23. doi: 10.3892/or.2018.6331.
    PubMed     Abstract available

  162. PAN Y, Sun H, Hu X, He B, et al
    The inhibitory role of miR4855p in colorectal cancer proliferation and invasion via targeting of CD147.
    Oncol Rep. 2018 Mar 12. doi: 10.3892/or.2018.6309.
    PubMed     Abstract available

  163. QI C, Chen Y, Zhou Y, Huang X, et al
    Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Oncol Rep. 2018 Mar 8. doi: 10.3892/or.2018.6303.
    PubMed     Abstract available

  164. FUJINO S, Miyoshi N, Ohue M, Takahashi Y, et al
    Plateletderived growth factor receptorbeta gene expression relates to recurrence in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6290.
    PubMed     Abstract available

  165. PARK HS, Kim BC, Yeo HY, Kim KH, et al
    Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6287.
    PubMed     Abstract available

  166. KANEKIYO S, Hazama S, Takenouchi H, Nakajima M, et al
    IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6288.
    PubMed     Abstract available

  167. ZENG X, Chen S, Lin Y, Ke Z, et al
    Acylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells.
    Oncol Rep. 2018;39:1387-1395.
    PubMed     Abstract available

  168. LIAO W, Li G, You Y, Wan H, et al
    Antitumor activity of Notch1 inhibition in human colorectal carcinoma cells.
    Oncol Rep. 2018;39:1063-1071.
    PubMed     Abstract available

    February 2018
  169. OKUGAWA Y, Yao L, Toiyama Y, Yamamoto A, et al
    Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6270.
    PubMed     Abstract available

  170. LI Y, Zhao L, Zhang Y, Guan L, et al
    Downregulation of the long non-coding RNA XLOC_010588 inhibits the invasion and migration of colorectal cancer.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6260.
    PubMed     Abstract available

  171. SHEN L, Dong X, Wang Y, Qiu L, et al
    beta3GnT8 regulates oxaliplatin resistance by altering integrin beta1 glycosylation in colon cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6243.
    PubMed     Abstract available

    January 2018
  172. ENDO S, Fujita M, Yamada S, Imadome K, et al
    Fra1 enhances the radioresistance of colon cancer cells to Xray or Cion radiation.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6223.
    PubMed     Abstract available

  173. XIONG Y, Wang J, Zhu H, Liu L, et al
    Chronic oxymatrine treatment induces resistance and epithelialmesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Oncol Rep. 2018 Jan 10. doi: 10.3892/or.2018.6204.
    PubMed     Abstract available

  174. GONG H, Fang L, Li Y, Du J, et al
    miR873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.
    Oncol Rep. 2018 Jan 8. doi: 10.3892/or.2018.6199.
    PubMed     Abstract available

  175. KIM IH, Nam TJ
    Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6193.
    PubMed     Abstract available

  176. SHIMADA T, Tsuruta M, Hasegawa H, Okabayashi K, et al
    Heat shock protein 27 knockdown using nucleotidebased therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6180.
    PubMed     Abstract available

  177. PHILLIPS E, Horniblow RD, Poole V, Bedford M, et al
    A potential role for hepcidin in obesity-driven colorectal tumourigenesis.
    Oncol Rep. 2018;39:392-400.
    PubMed     Abstract available

  178. WOHLLEBEN G, Hauff K, Gasser M, Waaga-Gasser AM, et al
    Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
    Oncol Rep. 2018;39:442-448.
    PubMed     Abstract available

  179. WANG Y, Xia C, Lun Z, Lv Y, et al
    Crosstalk between p38 MAPK and caspase-9 regulates mitochondria-mediated apoptosis induced by tetra-alpha-(4-carboxyphenoxy) phthalocyanine zinc photodynamic therapy in LoVo cells.
    Oncol Rep. 2018;39:61-70.
    PubMed     Abstract available

    December 2017
  180. ZHAO J, Xu J, Zhang R
    MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6135.
    PubMed     Abstract available

  181. YANG C, Wang MH, Zhou JD, Chi Q, et al
    Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling.
    Oncol Rep. 2017;38:3545-3553.
    PubMed     Abstract available

    November 2017
  182. CHEN M, Lin M, Wang X
    Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6110.
    PubMed     Abstract available

  183. RATTANAWONG A, Payon V, Limpanasittikul W, Boonkrai C, et al
    Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6084.
    PubMed     Abstract available

  184. LIN CS, Liu LT, Ou LH, Pan SC, et al
    Role of mitochondrial function in the invasiveness of human colon cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6087.
    PubMed     Abstract available

  185. LI J, Li X, Cen C, Ai X, et al
    The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6082.
    PubMed     Abstract available

  186. WANG D, Rai B, Qi F, Liu T, et al
    Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6076.
    PubMed     Abstract available

    October 2017
  187. ZHANG Y, Guo Y, Wang M, Dong H, et al
    Quercetrin from Toona sinensis leaves induces cell cycle arrest and apoptosis via enhancement of oxidative stress in human colorectal cancer SW620 cells.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6042.
    PubMed     Abstract available

  188. QUE K, Tong Y, Que G, Li L, et al
    Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6041.
    PubMed     Abstract available

  189. HE PY, Yip WK, Chai BL, Chai BY, et al
    Inhibition of cell migration and invasion by miR29a3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6037.
    PubMed     Abstract available

  190. TIAN XQ, Guo FF, Sun DF, Wang YC, et al
    Downregulation of ZNF278 arrests the cell cycle and decreases the proliferation of colorectal cancer cells via inhibition of the ERK/MAPK pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6031.
    PubMed     Abstract available

  191. LI X, Yang H, Ke J, Liu B, et al
    Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
    Oncol Rep. 2017;38:2317-2324.
    PubMed     Abstract available

  192. WU S, Wu F, Jiang Z
    Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Oncol Rep. 2017;38:2043-2050.
    PubMed     Abstract available

    September 2017
  193. LI K, Na K, Sang T, Wu K, et al
    The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6010.
    PubMed     Abstract available

  194. LIU X, Wang Y, Zhao J
    MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5997.
    PubMed     Abstract available

  195. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Abstract available

  196. FEI R, Zhang Y, Wang S, Xiang T, et al
    alpha7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5935.
    PubMed     Abstract available

    May 2017
  197. ANUPAMA S, Laha P, Sharma M, Pathak K, et al
    Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice.
    Oncol Rep. 2017;37:2803-2810.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.